Holen Sie sich die Stockscreener-App
6.4645
0.47%
0.0145
Schlusskurs vom Vortag:
$6.45
Offen:
$6.41
24-Stunden-Volumen:
233.67K
Relative Volume:
0.21
Marktkapitalisierung:
$268.28M
Einnahmen:
$134.48M
Nettoeinkommen (Verlust:
$-38.94M
KGV:
-6.7805
EPS:
-0.9534
Netto-Cashflow:
$-19.34M
1W Leistung:
-7.82%
1M Leistung:
+3.51%
6M Leistung:
-14.40%
1J Leistung:
-33.74%
1-Tages-Spanne:
$6.40
$6.655
1-Wochen-Bereich:
$6.05
$7.11
52-Wochen-Spanne:
$4.48
$13.22
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
6.45 | 268.28M | 134.48M | -38.94M | -19.34M | -0.9534 |
ABT
Abbott Laboratories
|
106.28 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.62 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
274.62 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.48 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.51 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Eingeleitet | William Blair | Mkt Perform |
| 2025-07-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Herabstufung | Jefferies | Buy → Hold |
| 2025-07-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Eingeleitet | Piper Sandler | Neutral |
| 2025-04-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-04 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
RxSight (RXST) ends employee option swap after 91.9% take-up - Stock Titan
RXST stock slips as insider selling and cash level draw attention - AD HOC NEWS
RxSight Officer Mark Wilterding to Sell 7,765 Shares Worth $54,044.40 to Cover Tax Withholding - Kalkine Media
RxSight stock edges higher after insider tax sales and Q2 beat - AD HOC NEWS
RxSight CFO Mark Wilterding sells $54,044 in company stock By Investing.com - Investing.com South Africa
RxSight COO Ilya Goldshleger sells $14,205 in company stock By Investing.com - Investing.com South Africa
RxSight CMO Ronald Kurtz sells $35,496 in shares for tax By Investing.com - Investing.com Australia
RxSight CFO Mark Wilterding sells $54,044 in company stock - Investing.com
RxSight COO Ilya Goldshleger sells $14,205 in company stock - Investing.com
RxSight CMO Ronald Kurtz sells $35,496 in shares for tax - Investing.com India
RxSight chief business development officer Eric Weinberg sells $14,205 in stock - Investing.com
RxSight (NASDAQ: RXST) officer plans 5,100-share sale to cover taxes - Stock Titan
RSU vesting at RxSight (NASDAQ: RXST) prompts insider share sale - Stock Titan
RxSight (RXST) officer to sell shares for taxes - Stock Titan
RxSight (RXST) CFO sells shares to cover RSU taxes - Stock Titan
RxSight (RXST) CMO vests 13,425 units, sells shares for taxes - Stock Titan
RxSight (RXST) COO sells 2,041 shares after RSU vest - Stock Titan
RxSight (RXST) exec’s stock sale only covers taxes - Stock Titan
Price to earnings forward of RxSight, Inc. – NASDAQ:RXST - TradingView
(RXST) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
RxSight stock holds in the lower single digits as losses narrow on stronger quarterly revenue - AD HOC NEWS
RxSight management is scheduled to speak in Boston on Sept. 9 - Stock Titan
RxSight (NASDAQ: RXST) refreshes documents for option exchange - Stock Titan
Tocqueville Asset Management L.P. Makes New Investment in RxSight, Inc. $RXST - MarketBeat
Steven Cohen’s Point72 discloses RxSight (RXST) stake - Stock Titan
RxSight (RXST) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison at the Close; Price Move - vinanet.vn
RxSight (RXST) Market: Moves 1.88% Higher to $6.49 in the Current Update; Boundary Watch: Support at $6.17 and Resistance at $6.81 Frame the Range on the DayATR Trailing Stop - vinanet.vn
Vitruvian Partners LLP Purchases New Holdings in RxSight, Inc. $RXST - MarketBeat
RxSight (RXST) Quarterly Figures: The Bottom-Line Figure Outpaces Its Comparison in Latest Trading; Price Reaction: The Stock Ends Down 1.70% in the Latest SessionGuidance Upgrade Report - Vinanet
RxSight (NASDAQ: RXST) ex-director to sell 11,890 shares - Stock Titan
Midday Stock Roundup: Eledon Falls 3.5% - Orange County Business Journal
RxSight (RXST) Close and Levels: Loses 2.31% to Close at $6.33 on the Day; Trading Range: Support at $6.01 and Resistance at $6.65 Frame the Range in the Available RecordAnchored VWAP - vinanet.vn
RxSight Inc. (RXST) Drops Nearly 6% as Shares Approach Key SupportMcClellan Summation - Vinanet
RxSight (RXST) Slips to $6.89 as Bearish Momentum Builds in Medical Device StockRVOL Spike - vinanet.vn
Walleye Capital LLC Takes Position in RxSight, Inc. $RXST - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
Alcon terminates PowerVision IOL programs, takes $402M write-off - MassDevice
Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery? - Yahoo Finance
RxSight (RXST) Q2 2026 Earnings Call Transcript - AOL.com
(RXST) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Azalea Vision Appoints Co-Founder Andrés Vasquez Quintero as Chief Executive Officer to Lead Next Phase of Clinical Development - AOL.com
Alcon Q2 Sales Rise on Strength in Vision Care, Surgical Segments - VisionMonday.com
Eye care company Alcon raises margin outlook, shares jump - marketscreener.com
Stifel cuts RxSight stock price target on competitive headwinds By Investing.com - Investing.com India
RxSight Inc. (RXST) PT Lowered to $7 at Stifel Amid U.S. Adoption Challenges - StreetInsider
Stifel Nicolaus Lowers RxSight (NASDAQ:RXST) Price Target to $7.00 - MarketBeat
Stifel cuts RxSight stock price target on competitive headwinds - Investing.com
RxSight (RXST) offers to swap 4.08M underwater options for new awards - Stock Titan
Stifel Maintains RxSight(RXST.US) With Hold Rating, Cuts Target Price to $7 - Moomoo
RxSight Reports Q2 Financial Results, Provides Update on 2026 Outlook - VisionMonday.com
The RxSight, Inc. (NASDAQ:RXST) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - 富途牛牛
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):